$190,000 of OWENS & MINOR INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution. Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution. FY 2026 Appropriations."
You can find more data on corporate lobbying on Quiver Quantitative.
OMI Insider Trading Activity
OMI insiders have traded $OMI stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OMI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM has made 3 purchases buying 1,537,852 shares for an estimated $8,099,544 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OMI Hedge Fund Activity
We have seen 117 institutional investors add shares of OMI stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,681,428 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $24,400,994
- VANGUARD GROUP INC removed 1,127,722 shares (-12.3%) from their portfolio in Q2 2025, for an estimated $10,262,270
- MILLENNIUM MANAGEMENT LLC added 1,056,505 shares (+1718.4%) to their portfolio in Q2 2025, for an estimated $9,614,195
- COLISEUM CAPITAL MANAGEMENT, LLC added 938,356 shares (+8.8%) to their portfolio in Q2 2025, for an estimated $8,539,039
- J. GOLDMAN & CO LP added 734,797 shares (+inf%) to their portfolio in Q2 2025, for an estimated $6,686,652
- D. E. SHAW & CO., INC. added 616,830 shares (+75.9%) to their portfolio in Q2 2025, for an estimated $5,613,153
- BLACKROCK, INC. removed 615,275 shares (-5.3%) from their portfolio in Q2 2025, for an estimated $5,599,002
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
OMI Analyst Ratings
Wall Street analysts have issued reports on $OMI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 08/12/2025
- Citigroup issued a "Buy" rating on 08/12/2025
- B of A Securities issued a "Underperform" rating on 08/12/2025
To track analyst ratings and price targets for OMI, check out Quiver Quantitative's $OMI forecast page.
OMI Price Targets
Multiple analysts have issued price targets for $OMI recently. We have seen 5 analysts offer price targets for $OMI in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Lisa Gill from JP Morgan set a target price of $6.0 on 08/27/2025
- Kevin Caliendo from UBS set a target price of $7.0 on 08/13/2025
- Eric Coldwell from Baird set a target price of $7.0 on 08/12/2025
- Daniel Grosslight from Citigroup set a target price of $7.0 on 08/12/2025
- Allen Lutz from B of A Securities set a target price of $4.75 on 08/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
